In previous models33, decreased FMRP favored loss of normal constraints on synaptic activity-induced protein synthesis (producing a net increase in APP and sAPPα cleavage product), leading to the FXS-like and autism-like symptoms in the animal. The gene discussed is FMR1; the disease is fragile X syndrome.